SPIMA Therapeutics
innovative peptide immunotherapy development
- B2B
About SPIMA Therapeutics
develops innovative peptide-based immunotherapies, targeting protein-protein interactions, for inflammatory and oncological diseases. Leads with a stapled peptide for Myddosome complex.
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Montpellier, Occitanie, France
- Founded
- 2024
- Revenue
- $3M – $23.5MTamtam estimate
- SIREN
- 927887562
- Website
- spima-therapeutics.com
SPIMA Therapeutics at a glance
SPIMA Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Montpellier, Occitanie, France.
SPIMA Therapeutics was founded in 2024.
SPIMA Therapeutics has 1–10 employees.
SPIMA Therapeutics's revenue is $3M – $23.5M (Tamtam estimate).
SPIMA Therapeutics's SIREN number is 927887562.
Selling to companies like SPIMA Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies